Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell wall and endotoxin components are essential structural and functional elements of the bacterial cell envelope that serve as primary targets for numerous antimicrobial agents (NIH, 2023). The cell wall, primarily composed of peptidoglycan in both Gram-positive and Gram-negative bacteria, provides mechanical strength and protects bacteria from osmotic lysis, while endotoxins, specifically lipopolysaccharides (LPS) in Gram-negative bacteria, are critical for outer membrane integrity and host immune activation (StatPearls, 2024). Drugs such as beta-lactams and glycopeptides target the synthesis and cross-linking of peptidoglycan, leading to bacterial cell death, whereas polymyxins interact directly with the lipid A component of LPS to disrupt the outer membrane (MDPI, 2021). Beyond their role as structural targets, these components are critical in the pathophysiology of sepsis and septic shock, where the massive release of endotoxin leads to systemic inflammation via TLR4 signaling (PubMed, 2022). Therapeutic strategies also include the neutralization of circulating endotoxins to mitigate inflammatory damage during severe infections. These components are highly conserved among bacteria but absent in human cells, making them ideal targets for selective toxicity, although their release during treatment can trigger severe inflammatory reactions like the Jarisch-Herxheimer reaction (NIH, 2024).
Inhibition of peptidoglycan cross-linking by binding to penicillin-binding proteins (PBPs), binding to D-alanyl-D-alanine precursors to prevent polymer elongation, and direct binding to lipopolysaccharide (LPS) to disrupt outer membrane integrity and neutralize endotoxin activity.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and endotoxin components.